Begin main content

Saxagliptin

Last Updated: May 9, 2013
Result type: Reports
Project Number: SR0329
Product Line: Common Drug Review

Generic Name: Saxagliptin

Brand Name: Onglyza

Manufacturer: Bristol-Myers Squibb / AstraZeneca Canada Inc.

Indications: Diabetes mellitus (Type 2)

Submission Type: Pre-NOC

Project Status: Complete

Date Recommendation Issued: November 15, 2013

Recommendation Type: List with criteria/condition